A detailed history of Obermeyer Wood Investment Counsel, Lllp transactions in Novo Nordisk A S stock. As of the latest transaction made, Obermeyer Wood Investment Counsel, Lllp holds 114,884 shares of NVO stock, worth $11.5 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
114,884
Previous 108,678 5.71%
Holding current value
$11.5 Million
Previous $15.5 Million 11.82%
% of portfolio
0.74%
Previous 0.89%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$119.07 - $145.42 $738,948 - $902,476
6,206 Added 5.71%
114,884 $13.7 Million
Q2 2024

Jul 31, 2024

BUY
$122.71 - $146.91 $10.9 Million - $13.1 Million
88,976 Added 451.61%
108,678 $15.5 Million
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $2.01 Million - $2.68 Million
19,702 New
19,702 $2.53 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $225B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Obermeyer Wood Investment Counsel, Lllp Portfolio

Follow Obermeyer Wood Investment Counsel, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Obermeyer Wood Investment Counsel, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Obermeyer Wood Investment Counsel, Lllp with notifications on news.